Switch to:
More From Other Websites
The Zacks Analyst Blog Highlights: Novartis, Roche, Shire, Neos and Novo Nordisk Jun 26 2017
SHIRE TO PRESENT NEW DATA AT ISTH 2017 TO ADVANCE THE STANDARD OF CARE IN HEMOPHILIA Jun 23 2017
Pharma Stock Roundup: NVS Scores with Positive Data, Shire ADHD Drug Gets FDA Nod Jun 23 2017
Shire (SHPG) Receives MAA Validation for Veyvondi by EMA Jun 22 2017
Biotech Movers: Shire, Bellicum, Organovo Jun 22 2017
Shire Announces EMA Validation of Veyvondi Marketing Authorization Application for Treatment of Von... Jun 22 2017
Shire's (SHPG) ADHD Drug Mydayis Receives Approval in US Jun 21 2017
Shire wins FDA approval for new ADHD drug Jun 21 2017
Shire's long-acting ADHD drug wins U.S. approval Jun 20 2017
Shire plc: U.S. FDA Approves Mydayis (Mixed Salts of a Single-Entity Amphetamine Product) - A New... Jun 20 2017
Could Shire PLC (SHPG) Be a Great Stock for Value Investors? Jun 19 2017
Do You Really Want to Love Your Medicines? Jun 19 2017
Valeant: Stop Looking in the Rearview Mirror! Jun 16 2017
10 High-Quality Foreign-Stock Bargains Jun 14 2017
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Shire plc (SHPG) Jun 08 2017
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Shire plc - SHPG Jun 07 2017
Down 24.6%, is BioCryst Pharmaceuticals Stock Now a Buy? Jun 06 2017
Key FDA Events to Watch Out for in Jun 2017 Jun 05 2017
Paulson & Co. Hedge Fund Cuts Back on Health Care in Q1 May 30 2017
Why BioCryst Pharmaceuticals Stock Caught Fire Today May 25 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK